Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
4
×
boston blog main
clinical trials
deals
fda
4
×
investing
4
×
life sciences
national blog main
san francisco blog main
4
×
boston top stories
eli lilly
national top stories
roche
san francisco top stories
venture capital
akouos
arrowmark partners
astellas pharmaceuticals
avapritinib
beta bionics
bigfoot biomedical
biofourmis
biovotion
blueprint medicines
boston university
california institute for biomedical research
chugai pharmaceutical
congenital hyperinsulinism
cstone pharmaceuticals
decibel therapeutics
dexcom
diabetes
drug delivery
edbi
edward damiano
european medicines agency
eventide asset management
fisogatinib
flatiron health
What
developing
drug
fda
medicines
million
patients
startup
therapeutics
treat
affects
americans
analytics
approval
approved
beta
biofourmis
bionics
blood
blueprint
cancer
candidate
closed
currently
data
date
device
devices
diabetes
digital
driven
employs
frequency
globally
hauls
heads
hearing
help
ipo
key
levels
Language
unset
Current search:
boston
×
" san francisco blog main "
×
fda
×
investing
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
